Intra-Cellular Therapies, Inc.
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Intra-Cellular Therapies, Inc.
RECRUITINGPhase 2NCT05766813
Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease
This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group, fixed-dose study in patients with a diagnosis of Parkinson's Disease consistent with the UK...
Sponsor: Intra-Cellular Therapies, Inc.Enrolling: 13220 locations
Parkinson Disease
RECRUITINGPhase 3NCT06229210
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism...
This is a multicenter, global, 26-week, open-label study to assess the safety and tolerability of lumateperone in pediatric patients with schizophrenia, bipolar disorder or autism...
Sponsor: Intra-Cellular Therapies, Inc.Enrolling: 50020 locations
SchizophreniaBipolar DisorderAutism Spectrum Disorder